Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents

Modern Pathology

Volumn 18, Issue 2, 2005, Pages 267-273

  Hu, Lulin ^a   Guo, Ming ^a   He, Zhi ^a   Thornton, Justin ^a   McDaniel, Larry S ^a   Hughson, Michael D ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Cervical intraepithelial neoplasia; Human papillomavirus; p16INK4a immunohistochemistry

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P16INK4A;

ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 13244262654     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800290     Document Type: Article

References (31)

1. Moscicki AB. Genital HPV infections in children and adolescents. Obst Gynec Clin North Am 1996;23:675-697.
2. Herrington CS, Evans MF, Hallam NF, et al. Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities. Br J Cancer 1995;71:206-209.
3. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-3114.
4. Woodman CBJ, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women; a longitudinal cohort study. Lancet 2001;357:1831-1836.
5. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995-3002.
6. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-284.
7. Stoler MH. Human papillomavirus biology and cervical neoplasia: implications for diagnostic criteria and testing. Arch Pathol Lab Med 2003;127:935-939.
8. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
9. Clavel C, Masure M, Bory JP, et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 1999;80:1306-1311.
10. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-428.
11. Franco EL, Villa LL, Sobrinho JP. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-1423.
12. Nakao Y, Yang X, Yokoyama M, et al. Induction of p16 during immortailization by HPV 16 and 18 and not during malignant transformation. Br J Cancer 1997;75:1410-1416.
13. INK4a protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153:1741-1748.
14. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, Cycle E, and p16INK4 are complementary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-891.
15. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervic uteri. Int J Cancer 2001;92:276-284.
16. Agoff SN, Lin P, Morihara J, et al. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003;16:665-673.
17. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
18. Banerjee SK, Makdisi WF, Weston AP, et al. Microwave-based DNA extraction from paraffin-embedded tissue for PCR amplification. BioTechniques 1995;17:768-773.
19. de Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-1062.
20. Adam E, Kaufman RH, Berkova Z, et al. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia? Am J Obstet Gynecol 1998;178:1235-1244.
21. Johnson TL, Joseph CLM, Caison-Sorey TJ, et al. Prevalence of HPV 16 and 18 DNA sequences in CIN III lesions of adults and adolescents. Diagn Cytopathol 1994;10:276-283.
22. Cuzick J, Terry G, Ho L, et al. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994;69:167-171.
23. Xin CY, Matsumoto K, Yoshikawa H, et al. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 2001;170:19-24.
24. Fujinaga Y, Shimada M, Okazawa K, et al. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991;72:1039-1044.
25. Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of high-risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002;325:572-578.
26. Clifford GM, Smith JS, Aguada T, et al. Comparison of HPV types distribution in high-grade cervical lesions and cervial cancer: a meta-analysis. Br J Cancer 2003;89:101-106.
27. Dalstein V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003;106:396-403.
28. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
29. INK4a than high-risk HPV testing for high-grade cervical intraepithelial neoplasm. Acta Cytol 2003;41:836.
30. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL triage study. Arch Pathol Lab Med 2003;127:946-949.
31. Wright Jr TC, Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.